Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AAA devices

This article was originally published in The Gray Sheet

Executive Summary

FDA approval of the Talent abdominal aortic aneurysm endovascular stent graft is expected by August 2002, the beginning of the firm's second fiscal quarter, Rasdal says. Medtronic currently is in discussions with the agency, following the completion of U.S. clinical trials. The device is the top-selling thoracic stent graft outside the U.S., Medtronic claims. Because the Talent is made from drawn nitinol wire, it should be more suitable for patients with aortic tortuosity than the firm's AneuRx AAA device, which FDA approved in September 1999, Rasdal suggested. Further back in development is a second-generation device, expected to be approved in the U.S. in the spring of 2004, that will leverage the "best" attributes of both the Talent and the AneuRx, according to Rasdal. The company expects the U.S. AAA market to grow to more than $600 mil. by Medtronic's 2006 fiscal year (beginning May 1), driven by an increased diagnosis of aortic aneurysms and a heightened acceptance of intravascular stent grafts
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT015518

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel